True Religion Unveils ‘New Year, New True’ Campaign
Continue reading →
Hong Kong Debuts Digital Platform to Centralize Cargo Tracking
The digital platform aims to unify shipment data across ocean, air and land transport and boost the port’s competitiveness as a global transshipment hub. Continue reading →
Insilico, newly listed in Hong Kong, strikes up to $888M oncology deal with Servier
Days after going public on the Hong Kong Stock Exchange, Insilico Medicine has struck a multi-year oncology drug discovery partnership with France’s Servier worth up to $888 million. The collaboration will focus on developing oncology therapies, by combining Insilico’s AI-driven drug discovery platforms with Servier’s global expertise in cancer drug development. Insilico...
Wegovy pill hits market at $299 per month
The first FDA-approved oral GLP-1 for weight loss is now available to U.S. patients for $299 per month through a self-pay platform. Self-paying patients can order the Wegovy pill at $149 per month as they work up to the two highest doses, which are available at $299 per month, according to a Jan. 5 news release from Novo Nordisk, a drugmaker based in Denmark. ...
Erlanger taps SVP of revenue cycle from CommonSpirit
Chattanooga, Tenn.-based Erlanger Health System has named Chris Spady senior vice president of revenue cycle, according to a post on his LinkedIn page. Mr. Spady returns to Erlanger after serving as Southeast Division vice president of revenue cycle for Chicago-based CommonSpirit for the past two-and-a-half years. He had served as Erlanger’s vice president from...
Elon Musk: Neuralink to boost production, automate surgeries
Neuralink plans to step up production of its brain implants and move to automated procedures in 2026, Elon Musk posted on X. Musk’s company has been placing the computer chips inside the brains of paralyzed patients as part of a clinical trial, including at University of Miami Health System in April. The company also raised $650 million and hired a former FDA...
The State of Cybersecurity in 2025: Key Segments, Insights, and Innovations
Featuring: Cybersecurity is being reshaped by forces that extend beyond individual threats or tools. As organizations operate across cloud infrastructure, distributed endpoints, and complex supply chains, security has shifted from a collection of point solutions to a question of architecture, trust, and execution speed. This report examines how core areas of cybersecurity...
⚡ Weekly Recap: IoT Exploits, Wallet Breaches, Rogue Extensions, AI Abuse & More
The year opened without a reset. The same pressure carried over, and in some places it tightened. Systems people assume are boring or stable are showing up in the wrong places. Attacks moved quietly, reused familiar paths, and kept working longer than anyone wants to admit. This week’s stories share one pattern. Nothing flashy. No single moment. Just steady abuse of trust —...
What can non-coding DNA tell us about Alzheimer’s disease?
Original story from the University of New South Wales (Sydney). Researchers have revealed that so-called ‘junk DNA’ contains powerful switches that help control brain cells linked to Alzheimer’s disease. When people picture DNA, they often imagine a set of genes that shape our physical traits, influence behavior and help keep our cells and organs functioning. But genes make...
Strategic diagnostic testing partnerships are accelerating clinical research
With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex era. Continue reading →
10 clinical trials to watch in the first half of 2026
After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease and many rare conditions could help it continue. Continue reading →
